Sherbrooke, Canada

Mark L Peterson

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 5.3

ph-index = 10

Forward Citations = 196(Granted Patents)


Location History:

  • Rock Forest, CA (2008 - 2011)
  • Québec, CA (2009 - 2013)
  • Sherbrooke, CA (2009 - 2021)

Company Filing History:


Years Active: 2008-2021

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: Mark L. Peterson: A Pioneer in Macrocyclic Compound Research

Introduction: Mark L. Peterson, a distinguished inventor based in Sherbrooke, Canada, has made significant contributions to the field of drug discovery. With an impressive portfolio of 21 patents, his expertise in macrocyclic compounds and their applications in pharmaceutical research sets him apart as a leading figure in the industry.

Latest Patents: Among his notable innovations, Peterson's latest patents focus on "Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the same." This patent disclosure details novel macrocyclic compounds that contain heteroaryl moieties, which serve as valuable research tools for drug discovery efforts. The methodologies outlined include preparation and utilization of these compounds in high-throughput screening, proving crucial for evaluating bioactivity at numerous pharmacologically relevant targets. This includes G protein-coupled receptors, nuclear receptors, enzymes, ion channels, transporters, transcription factors, as well as protein-protein and nucleic acid-protein interactions. Consequently, these innovative libraries contribute significantly to the search for new pharmaceutical agents aimed at treating and preventing various medical conditions.

Career Highlights: Throughout his career, Mark L. Peterson has worked with several prominent organizations. Notably, he has been associated with Tranzyme Pharma Inc. and Ocera Therapeutics, Inc., where he has further honed his expertise in pharmaceutical innovation.

Collaborations: During his professional journey, Peterson has collaborated with notable coworkers such as Hamid R. Hoveyda and Graeme Lovat Fraser. These partnerships have enhanced his research and development efforts, driving forward advancements in the field.

Conclusion: Mark L. Peterson continues to leave an indelible mark on the landscape of drug discovery through his innovative work on macrocyclic compounds. His significant contributions, supported by a robust patent portfolio, highlight the impact of his research in the pursuit of new therapeutic agents. As the pharmaceutical industry evolves, the advancements leading from Peterson's inventions are sure to play a vital role in shaping future medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…